Literature DB >> 26240708

Efficacy of Antibiotics Sprayed into Surgical Site for Prevention of the Contamination in the Spinal Surgery.

Bo-Kyung Suh1, Seong-Hwan Moon2, Tae-Hwan Kim1, Jae Keun Oh3, Yong Shin Kwon1, Jung-Seob Park4, Moon Soo Park1.   

Abstract

STUDY
DESIGN: Retrospective study.
PURPOSE: To evaluate the effect of intraoperative wound application of vancomycin on preventing surgical wound contamination during instrumented lumbar spinal surgery. OVERVIEW OF LITERATURE: Postoperative infection is the one of the most devastating complications of lumbar surgery. There are a few reports showing the benefits of intraoperative wound application of vancomycin during spinal surgery. However, there is no report about the effectiveness of local vancomycin instillation in prevention of surgical wound contamination.
METHODS: Eighty-six patients underwent instrumented lumbar spinal surgery. Mean patient age was 65.19 years (range, 23-83 years). There were 67 females and 19 males. During surgery, vancomycin powder was applied into the surgical site before closure in 43 patients (antibiotic group) and vancomycin powder was not applied into the surgical site before closure in 43 patients (control group). The tip of the surgical drain was cultured to evaluate surgical wound contamination. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured on the first, third, seventh, and fourteenth day after the operation.
RESULTS: We found two patients with a positive culture from the tip of surgical drains in the antibiotic group, and one patient with a positive culture from the tip of the surgical drain in the control group. Postoperative ESR and CRP levels did not show significant differences between the two groups. On the third postoperative day, ESR in patients of the antibiotic group was more significantly decreased than that in patients of the control group, while CRP level did not show a significant difference between the two groups.
CONCLUSIONS: There was no evidence to suggest that intraoperative vancomycin application is effective in decreasing the risk of postoperative wound infection after instrumented posterior lumbar fusion surgery.

Entities:  

Keywords:  Contamination; Fusion; Lumbar spine; Vancomycin

Year:  2015        PMID: 26240708      PMCID: PMC4522439          DOI: 10.4184/asj.2015.9.4.517

Source DB:  PubMed          Journal:  Asian Spine J        ISSN: 1976-1902


  13 in total

1.  Early-phase enhanced inflammatory reaction after spinal instrumentation surgery.

Authors:  J Takahashi; S Ebara; M Kamimura; T Kinoshita; H Itoh; Y Yuzawa; Y Sheena; K Takaoka
Journal:  Spine (Phila Pa 1976)       Date:  2001-08-01       Impact factor: 3.468

2.  Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period.

Authors:  Robert W Molinari; Oner A Khera; William J Molinari
Journal:  Eur Spine J       Date:  2011-12-08       Impact factor: 3.134

3.  THE USE OF ANTIBIOTICS, LOCALLY AND SYSTEMICALLY, IN ORTHOPEDIC SURGERY.

Authors:  W B MAGUIRE
Journal:  Med J Aust       Date:  1964-09-12       Impact factor: 7.738

4.  Surgical site infection in spinal surgery: detection and management based on serial C-reactive protein measurements.

Authors:  Byung-Uk Kang; Sang-Ho Lee; Yong Ahn; Won-Chul Choi; Young-Geun Choi
Journal:  J Neurosurg Spine       Date:  2010-08

5.  Risk factors for deep surgical site infections after spinal fusion.

Authors:  J J P Schimmel; P P Horsting; M de Kleuver; G Wonders; J van Limbeek
Journal:  Eur Spine J       Date:  2010-05-06       Impact factor: 3.134

6.  Topical antibiotic prophylaxis in neurosurgery.

Authors:  S J Haines
Journal:  Neurosurgery       Date:  1982-08       Impact factor: 4.654

7.  Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder.

Authors:  Kevin R O'Neill; Jason G Smith; Amir M Abtahi; Kristin R Archer; Dan M Spengler; Matthew J McGirt; Clinton J Devin
Journal:  Spine J       Date:  2011-05-19       Impact factor: 4.166

8.  The C-reactive protein for detection of early infections after lumbar microdiscectomy.

Authors:  B Meyer; K Schaller; V Rohde; W Hassler
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes.

Authors:  Fred A Sweet; Michael Roh; Christopher Sliva
Journal:  Spine (Phila Pa 1976)       Date:  2011-11-15       Impact factor: 3.468

Review 10.  Postoperative spinal wound infections.

Authors:  Rick C Sasso; Ben J Garrido
Journal:  J Am Acad Orthop Surg       Date:  2008-06       Impact factor: 3.020

View more
  5 in total

Review 1.  Effect of Intra-wound Vancomycin for Spinal Surgery: A Systematic Review and Meta-analysis.

Authors:  Lun-Li Xie; Jun Zhu; Mao-Sheng Yang; Chang-Yuan Yang; Shun-Hong Luo; Yu Xie; Dan Pu
Journal:  Orthop Surg       Date:  2017-11       Impact factor: 2.071

Review 2.  Do Dose-Dependent Microbial Changes Occur during Spine Surgery as a Result of Applying Intrawound Vancomycin Powder?: A Systematic Literature Review.

Authors:  Lunli Xie; Jun Zhu; Shunhong Luo; Yu Xie; Dan Pu
Journal:  Asian Spine J       Date:  2018-02-07

3.  The effectiveness of pedicle screw immersion in vancomycin and ceftriaxone solution for the prevention of postoperative spinal infection: A prospective comparative study.

Authors:  Burak Eren; Feyza Karagöz Güzey; Serkan Kitiş; Nezih Özkan; Cafer Korkut
Journal:  Acta Orthop Traumatol Turc       Date:  2018-06-07       Impact factor: 1.511

Review 4.  Prophylactic Topical Antibiotics in Fracture Repair and Spinal Fusion.

Authors:  Eric K Kim; Claire A Donnelley; Madeline Tiee; Heather J Roberts; Ericka Von Kaeppler; David Shearer; Saam Morshed
Journal:  Adv Orthop       Date:  2021-10-14

5.  Prophylactic Intrawound Vancomycin Powder in Minimally Invasive Spine Stabilization May Cause an Acute Inflammatory Response.

Authors:  Yuki Hyodo; Takeshi Arizono; Akihiko Inokuchi; Takahiro Hamada; Ryuta Imamura
Journal:  Cureus       Date:  2022-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.